Literature DB >> 11716108

Risk factors for gametocyte carriage in Gambian children.

L von Seidlein1, C Drakeley, B Greenwood, G Walraven, G Targett.   

Abstract

A widespread reduction in Plasmodium falciparum gametocyte prevalence could reduce malaria transmission. After infection with P. falciparum, a variable proportion of people are found to be gametocytemic. We analyzed risk factors associated with gametocytemia at presentation and 7 days later. We enrolled 1,198 children in 2 antimalarial drug trials between September and December 1998. The children were assigned to 1 of 4 treatment groups: chloroquine only; pyrimethamine-sulfadoxine (PSD) only; PSD combined with 1 dose of artesunate; and PSD combined with 3 doses of artesunate. By the time of enrollment, 200 (17%) of 1,198 children were gametocyte carriers. Three independent risk factors were associated with gametocytemia at enrollment. Children with anemia were more likely to carry gametocytes, whereas children with fever (> 37.4 degrees C) or high parasite densities (> 100,000 parasites/microL) were less frequently gametocyte carriers. Children with at least 2 of the risk factors were 4 times more likely to be gametocytemic than children with < 2 risk factors (odds ratio [OR], 4.4; 95% confidence interval [CI], 2.7-7.1). Seven days after the start of treatment, 355 (37%) of 466 assessable children were found to be gametocyte carriers. Children treated with PSD alone had a significantly higher risk of being gametocytemic by Day 7 compared with children in the other 3 treatment groups. In the subgroup of children who had no detectable gametocytes on enrollment, the effect of treatment with PSD + 3 doses of artesunate was most marked. Nineteen (10%) of 198 children treated with PSD + 3 doses of artesunate became gametocytemic, in contrast to 184 (57%) of 321 children treated with PSD alone (OR, 12.7; 95% CI, 7.3-22.1). Early treatment with highly effective antimalarial therapy has the greatest chance of preventing gametocytemia. The choice of a first-line antimalarial drug for uncomplicated malaria should not only take into consideration the ablation asexual parasitemia but also the suppression of gametocytemia.

Entities:  

Mesh:

Year:  2001        PMID: 11716108     DOI: 10.4269/ajtmh.2001.65.523

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  42 in total

Review 1.  Sexual development in Plasmodium parasites: knowing when it's time to commit.

Authors:  Gabrielle A Josling; Manuel Llinás
Journal:  Nat Rev Microbiol       Date:  2015-09       Impact factor: 60.633

2.  Dynamics of Plasmodium falciparum parasitemia regarding combined treatment regimens for acute uncomplicated malaria, Antioquia, Colombia.

Authors:  Gonzalo Alvarez; Alberto Tobón; Juan-Gabriel Piñeros; Alexandra Ríos; Silvia Blair
Journal:  Am J Trop Med Hyg       Date:  2010-07       Impact factor: 2.345

Review 3.  Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination.

Authors:  Teun Bousema; Chris Drakeley
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

4.  Molecular evidence for the localization of Plasmodium falciparum immature gametocytes in bone marrow.

Authors:  Ruth Aguilar; Ariel Magallon-Tejada; Ariel H Achtman; Cinta Moraleda; Regina Joice; Pau Cisteró; Connie S N Li Wai Suen; Augusto Nhabomba; Eusebio Macete; Ivo Mueller; Matthias Marti; Pedro L Alonso; Clara Menéndez; Louis Schofield; Alfredo Mayor
Journal:  Blood       Date:  2013-12-13       Impact factor: 22.113

5.  The effects of ACT treatment and TS prophylaxis on Plasmodium falciparum gametocytemia in a cohort of young Ugandan children.

Authors:  Abel Kakuru; Prasanna Jagannathan; Emmanuel Arinaitwe; Humphrey Wanzira; Mary Muhindo; Victor Bigira; Emmanuel Osilo; Jaco Homsy; Moses R Kamya; Jordan W Tappero; Grant Dorsey
Journal:  Am J Trop Med Hyg       Date:  2013-02-04       Impact factor: 2.345

Review 6.  Plasmodium Gametocytes in Field Studies: Do We Measure Commitment to Transmission or Detectability?

Authors:  Cristian Koepfli; Guiyun Yan
Journal:  Trends Parasitol       Date:  2018-03-12

7.  Sulfadoxine-pyrimethamine in treatment of malaria in Western Kenya: increasing resistance and underdosing.

Authors:  Dianne J Terlouw; Bernard L Nahlen; Jeanne M Courval; Simon K Kariuki; Oren S Rosenberg; Aggrey J Oloo; Margarette S Kolczak; William A Hawley; Altaf A Lal; Feiko O ter Kuile
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

8.  Loop-mediated isothermal amplification assay for rapid diagnosis of malaria infections in an area of endemicity in Thailand.

Authors:  Jetsumon Sattabongkot; Takafumi Tsuboi; Eun-Taek Han; Sirasate Bantuchai; Sureemas Buates
Journal:  J Clin Microbiol       Date:  2014-02-26       Impact factor: 5.948

9.  Bimodal transmission of cerebral malaria and severe malarial anemia and reciprocal co-existence of sexual and asexual parasitemia in an area of seasonal malaria transmission.

Authors:  Hayder A Giha; Mustafa I Elbashir; Ishraga E A-Elbasit; Thoraya M E A-Gadir; Gehad ElGhazali
Journal:  Parasitol Res       Date:  2008-06       Impact factor: 2.289

10.  Effects of mefloquine and artesunate mefloquine on the emergence, clearance and sex ratio of Plasmodium falciparum gametocytes in malarious children.

Authors:  Akintunde Sowunmi; Oluchi O Nkogho; Titilope M Okuboyejo; Grace O Gbotosho; Christian T Happi; Elsie O Adewoye
Journal:  Malar J       Date:  2009-12-16       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.